BEHÇET'S SYNDROME (BS)
Clinical trials for BEHÇET'S SYNDROME (BS) explained in plain language.
Never miss a new study
Get alerted when new BEHÇET'S SYNDROME (BS) trials appear
Sign up with your email to follow new studies for BEHÇET'S SYNDROME (BS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets immune diseases in early trial
Disease control Recruiting nowThis early-stage study tests a new drug called RAY121 in people with six different immune system diseases, including antiphospholipid syndrome and bullous pemphigoid. The main goal is to check safety and how the body processes the drug. About 144 adults will take part to see if t…
Matched conditions: BEHÇET'S SYNDROME (BS)
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 17, 2026 06:44 UTC
-
New hope for Behçet's sufferers: biosimilar drug under study for stubborn sores
Disease control Recruiting nowThis study looks at how well a biosimilar of ustekinumab works for people with Behçet's syndrome who have painful mouth and genital sores that didn't get better with standard treatments. Researchers will track 208 adults over 52 weeks to see if the drug stops these sores without …
Matched conditions: BEHÇET'S SYNDROME (BS)
Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil • Aim: Disease control
Last updated May 05, 2026 11:54 UTC